‘Super jelly’ can survive being run over by a car

Researchers have developed a jelly-like material that can withstand the equivalent of an elephant standing on it, and completely recover to its original shape, even though it’s 80 per cent water. The soft-yet-strong material, developed...

Teaching old oaks new tricks

Mature oak trees will increase their rate of photosynthesis by up to a third in response to the raised CO2 levels expected to be the world average by about 2050, new research shows. The results, published...

New microscope uses photonics for insights into ‘superbugs’

Scientists are building a new super-resolution microscope that uses laser light to study the inner workings and behaviours of superbugs to gain new insights into how they cause disease. The microscope will allow scientists to...

Spider web secrets unravelled

American scientists are the first to document every step of web-building. Johns Hopkins University researchers discovered precisely how spiders build webs by using night vision and artificial intelligence to track and record every movement of...

USA Based Angstrom Technology Acquire UK Market-Leader Connect 2 Cleanrooms

ASGARD Partners & Co., LLC ("ASGARD"), a New York-based private equity firm, today announced that its portfolio company, Angstrom Technology ("Angstrom" or the "Company"), an industry leader in modular cleanroom design and production, has signed...

Connect 2 Cleanrooms and RoslinCT partner to introduce new GMP Cell and Gene Therapy...

Connect 2 Cleanrooms (C2C), in partnership with RoslinCT, is pleased to present the new state-of-the-art GMP manufacturing facility and training laboratory at RoslinCT’s BioCube building in Edinburgh’s BioQuarter. RoslinCT is a cell therapy Contract Development...

Pioneering breakthrough in treatment of ‘devastating’ neurological disorder

IntraBio Inc has announced positive data from its multinational clinical trial of IB1001 for the treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease). IB1001 demonstrated a statistically significant and clinically meaningful improvement in symptoms, functioning,...

Covid portal start-up exceeds 1 million tests and creates offshoot venture

As the UK continues learning how to live with the pandemic, some key questions remain. Chiefly, how will the NHS grapple with the huge diagnosis and treatment backlog that has built up, and will...

Cleaning breakthrough for listeria elimination

All traces of listeria spp in a highly sensitive food production environment have been successfully eliminated in a breakthrough pilot. The 11-week proof of concept saw Bio-Fence antimicrobial coatings applied to the floor and lower...

AI could improve diagnosis for over 100,000 prostate patients in UK

The use of AI to identify prostate cancer is currently being validated in the first retrospective study of its kind in the UK. Real-world data from hospitals and scanner types is being scrutinised, to show...

Advances in longitudinal RWD and genomics access for drug development in Africa

A new partnership aims to build the largest integrated clinical and genomics data biobank in Africa, representing a major boost for RWD research across the continent. The collaboration is between BC Platforms (BCP), a global...

Lung cancer treatment is a UK first

A grandfather has become the UK’s first lung cancer patient to benefit from a state-of-art radiotherapy treatment at The Christie NHS Foundation Trust. Barry Staniforth, 81, was treated using the Elekta MR-guided linear accelerator (MR-linac)...

Novel mechanism links IBD genetic defect to gut leakiness

A study into ‘leaky gut’ is the first to show how a disease mutation increases the risk of developing Inflammatory Bowel Disease (IBD). Researchers led by a biomedical scientist at the University of California, Riverside,...

New approach will help identify drugs that can ‘glue’ proteins together

A new screening method that can test the effectiveness of therapeutic molecules designed to ‘glue’ proteins together in the body has been developed by researchers at the University of Birmingham and the University of...

Protecting Digital Medtech Innovation

For many years the medical technology (medtech) sector has been at the forefront of innovation and the Covid-19 pandemic has not slowed it down, with new technology quickly being developed to test for, prevent...

Antimicrobial resistance ‘arms race’ heats up

An advanced interventional microbiomics company, which is developing non-antibiotic methods for the control of multiple-drug resistant superbugs and other infectious disease, is stepping up development of a cure for antibiotic resistant bacteria. BioPlx has set...